229 related articles for article (PubMed ID: 22204661)
1. Long-term prognosis of breast cancer detected by mammography screening or other methods.
Lehtimäki T; Lundin M; Linder N; Sihto H; Holli K; Turpeenniemi-Hujanen T; Kataja V; Isola J; Joensuu H; Lundin J
Breast Cancer Res; 2011; 13(6):R134. PubMed ID: 22204661
[TBL] [Abstract][Full Text] [Related]
2. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
3. Survival of women ages 40-49 years with breast carcinoma according to method of detection.
McPherson CP; Swenson KK; Jolitz G; Murray CL
Cancer; 1997 May; 79(10):1923-32. PubMed ID: 9149019
[TBL] [Abstract][Full Text] [Related]
4. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
5. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project.
Byrne C; Smart CR; Chu KC; Hartmann WH
Cancer; 1994 Jul; 74(1 Suppl):301-10. PubMed ID: 8004601
[TBL] [Abstract][Full Text] [Related]
6. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
7. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
9. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
10. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
Heimann R; Munsell M; McBride R
Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
[TBL] [Abstract][Full Text] [Related]
11. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
12. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
13. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?
James JJ; Evans AJ; Pinder SE; Macmillan RD; Wilson AR; Ellis IO
Clin Radiol; 2003 Jan; 58(1):54-62. PubMed ID: 12565206
[TBL] [Abstract][Full Text] [Related]
14. Method of tumor detection influences disease-free survival of women with breast carcinoma.
Senie RT; Lesser M; Kinne DW; Rosen PP
Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
[TBL] [Abstract][Full Text] [Related]
15. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of minimal breast cancer: a pathologist's viewpoint.
Wirman JA
Crit Rev Oncol Hematol; 1985; 3(1):35-74. PubMed ID: 2990747
[TBL] [Abstract][Full Text] [Related]
17. Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.
Iwasaki Y; Fukutomi T; Akashi-Tanaka S; Nanasawa T; Tsuda H
Jpn J Clin Oncol; 1998 Oct; 28(10):601-3. PubMed ID: 9839499
[TBL] [Abstract][Full Text] [Related]
18. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
[TBL] [Abstract][Full Text] [Related]
19. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
20. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
